Compound Detail
CHEMBL527
PIROXICAM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL527 |
| Name | PIROXICAM |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | QYSPLQLAKJAUJT-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
13
Targets
26
Activities
2
Assay Types
4
PK Parameters
20
Publications
15
Known Names
11
Indications
1
Mechanisms
Molecular Properties
331.4
MW (Da)
1.58
ALogP
5
HBA
2
HBD
99.6
PSA (Ų)
0.87
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1982 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cyclooxygenase inhibitor | INHIBITOR | Cyclooxygenase | ✓ | ✓ |
Indications
Arthralgia Arthritis, Rheumatoid Eye Diseases Myalgia Osteoarthritis Rheumatic Diseases Renal Colic Wounds and Injuries Osteoarthritis, Knee Tennis Elbow Pain
ATC Classification
M01AC01
piroxicam
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M02AA07
piroxicam
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
S01BC06
piroxicam
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS
Drug Warnings
Black Box Warning
cardiotoxicity
Black Box Warning
neurotoxicity
Black Box Warning
gastrointestinal toxicity
Activity Summary
IC50 21 meas. best 7.0
Ki 5 meas. best 5.31
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cyclooxygenase CHEMBL2095157 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Rattus norvegicus CHEMBL376 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Prostaglandin G/H synthase 1 CHEMBL221 | IC50 | 5.89 | 5.28 | 1300.0 | 3 |
| Organic anion transporter 3 CHEMBL1641348 | Ki | 5.31 | 5.31 | 4880.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.0 | 4.9667 | 10000.0 | 3 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.75 | 4.75 | 18000.0 | 1 |
| THP-1 CHEMBL614245 | IC50 | 4.74 | 4.705 | 18100.0 | 2 |
| Solute carrier family 22 member 6 CHEMBL1641347 | Ki | 4.7 | 4.7 | 19800.0 | 1 |
| Solute carrier family 22 member 6 CHEMBL1641347 | IC50 | 4.69 | 4.69 | 20500.0 | 1 |
| Prostaglandin G/H synthase 1 CHEMBL2949 | IC50 | 4.68 | 4.68 | 21000.0 | 1 |
| Solute carrier family 22 member 6 CHEMBL1777665 | Ki | 4.28 | 4.28 | 52000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.2 | 4.2 | 62600.0 | 1 |
| Cyclooxygenase CHEMBL2096674 | IC50 | 4.19 | 4.19 | 65000.0 | 1 |
| Prostaglandin G/H synthase 2 CHEMBL230 | IC50 | 4.05 | 4.05 | 89125.1 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Cmax | 47.8 | nmol/g | Rattus norvegicus |
| F | 100.0 | % | Homo sapiens |
| F | 100.0 | % | Homo sapiens |
| F | 100.0 | % | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine